Histology and anatomic pathology laboratories operate at the intersection of patient safety, regulatory compliance, and institutional liability.
Operational weaknesses in specimen handling, documentation, or quality systems can lead to:
- Diagnostic delays
- Inspection citations
- Reputational risk
- Increased malpractice exposure
Executive-level compliance oversight ensures:
- Alignment with CLIA and CAP standards
- Workflow integrity from accessioning through diagnosis
- Documented competency and quality assurance
- Reduced risk of repeat regulatory findings
- Strengthened defensibility in the event of complaint or litigation
Laboratory risk management is not solely a technical issue — it is an institutional protection strategy.
The most effective way to reduce regulatory and legal exposure is to build strong, well-documented systems before vulnerabilities surface.